Core Insights - Auna reported solid financial and operational performance in Peru and Colombia, while facing challenges in Mexico, indicating resilience in its integrated healthcare platform [3][4][6] Financial Performance - Consolidated Revenue increased by 1% in constant currency (FXN) but decreased by 1% year-over-year (YoY) to S/1,117 million, with local currency revenues growing by 9% in Peru and 4% in Colombia, offset by a 12% decline in Mexico [8][10] - Adjusted EBITDA decreased by 5% FXN and 7% YoY to S/232 million, with a margin of 20.8%, down from 22.1% YoY; Peru and Colombia saw increases of 15% and 18% in local currency, respectively, while Mexico experienced a 29% decline [8][11] - Net Income was S/53 million in 3Q25, down from S/101 million in 3Q24, with Adjusted Net Income at S/58 million compared to S/75 million in the prior year [13] Operational Highlights - In Peru, Oncosalud and Healthcare Services showed strong performance due to growth in memberships and pricing adjustments, with an improved Oncology Medical Loss Ratio (MLR) of 49.3% [4][8] - Colombia achieved double-digit growth in Adjusted EBITDA and expanded risk-sharing Prospective Global Payment models, enhancing profitability and cash generation [5][8] - Mexico's operations saw a second consecutive quarterly increase in surgeries and growth in oncology and cardiology services, but overall revenues and profitability declined due to sluggish demand and operational challenges [6][10] Debt and Capital Structure - Auna's leverage ratio remained stable at 3.6x Net Debt-to-Adjusted EBITDA, with a focus on capital allocation and a robust cash position; the company completed a USD765 million debt refinancing to extend maturities and reduce interest costs [7][8] Strategic Initiatives - The company is focused on recovering growth, rolling out the AunaWay initiative in Mexico, and expanding access to high-quality healthcare across Spanish-speaking Latin America [9][10]
Auna Announces 3Q25 Financial Results